Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach

被引:14
作者
Blazquez-Navarro, Arturo [1 ,2 ]
Schachtner, Thomas [1 ,3 ]
Stervbo, Ulrik [1 ,4 ]
Sefrin, Anett [3 ]
Stein, Maik [1 ]
Westhoff, Timm H. [4 ]
Reinke, Petra [1 ,3 ]
Klipp, Edda [5 ]
Babel, Nina [1 ,4 ]
Neumann, Avidan U. [1 ,6 ,7 ]
Or-Guil, Michal
机构
[1] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany
[2] Humboldt Univ, Dept Biol, Syst Immunol Lab, Berlin, Germany
[3] Charite, Dept Nephrol & Internal Intens Care, Berlin, Germany
[4] Ruhr Univ Bochum, Marien Hosp Herne, Med Clin 1, Herne, Germany
[5] Humboldt Univ, Dept Biol, Theoret Biophys Grp, Berlin, Germany
[6] Helmholtz Zentrum Munchen, UNIKA T, Inst Environm Med, Augsburg, Germany
[7] Helmholtz Zentrum Munchen, Inst Computat Biol, Munich, Germany
关键词
POLYOMAVIRUS BK; IN-VIVO; TRANSPLANT RECIPIENTS; NEPHROPATHY; IMMUNITY; REPLICATION; INFECTION;
D O I
10.1371/journal.pcbi.1005998
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
BK virus (BKV) associated nephropathy affects 1-10% of kidney transplant recipients, leading to graft failure in about 50% of cases. Immune responses against different BKV antigens have been shown to have a prognostic value for disease development. Data currently suggest that the structural antigens and regulatory antigens of BKV might each trigger a different mode of action of the immune response. To study the influence of different modes of action of the cellular immune response on BKV clearance dynamics, we have analysed the kinetics of BKV plasma load and anti-BKV T cell response (Elispot) in six patients with BKV associated nephropathy using ODE modelling. The results show that only a small number of hypotheses on the mode of action are compatible with the empirical data. The hypothesis with the highest empirical support is that structural antigens trigger blocking of virus production from infected cells, whereas regulatory antigens trigger an acceleration of death of infected cells. These differential modes of action could be important for our understanding of BKV resolution, as according to the hypothesis, only regulatory antigens would trigger a fast and continuous clearance of the viral load. Other hypotheses showed a lower degree of empirical support, but could potentially explain the clearing mechanisms of individual patients. Our results highlight the heterogeneity of the dynamics, including the delay between immune response against structural versus regulatory antigens, and its relevance for BKV clearance. Our modelling approach is the first that studies the process of BKV clearance by bringing together viral and immune kinetics and can provide a framework for personalised hypotheses generation on the interrelations between cellular immunity and viral dynamics.
引用
收藏
页数:20
相关论文
共 36 条
[1]  
[Anonymous], ECOLOGICAL MODELLING
[2]   BK polyomavirus infection and nephropathy: the virus-immune system interplay [J].
Babel, Nina ;
Volk, Hans-Dieter ;
Reinke, Petra .
NATURE REVIEWS NEPHROLOGY, 2011, 7 (07) :399-406
[3]   Sustained BK Viruria as an Early Marker for the Development of BKV-Associated Nephropathy: Analysis of 4128 Urine and Serum Samples [J].
Babel, Nina ;
Fendt, Juliane ;
Karaivanov, Stoyan ;
Bold, Gantuja ;
Arnold, Steffen ;
Sefrin, Anett ;
Lieske, Evelyn ;
Hoffzimmer, Martin ;
Dziubianau, Mikalai ;
Bethke, Nicole ;
Meisel, Christian ;
Gruetz, Gerald ;
Reinke, Petra .
TRANSPLANTATION, 2009, 88 (01) :89-95
[4]   UNCERTAINTY QUANTIFICATION IN MODELING HIV VIRAL MECHANICS [J].
Banks, H. T. ;
Baraldi, Robert ;
Cross, Karissa ;
Flores, Kevin ;
Mcchesney, Christina ;
Poag, Laura ;
Thorpe, Emma .
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2015, 12 (05) :937-964
[5]   Surveillance and Modification of Immunosuppression Minimizes BK Virus Nephropathy [J].
Bennett, William M. ;
Meyer, Leslie ;
Ridenour, Jennifer ;
Batiuk, Thomas D. .
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 32 (01) :10-12
[6]   Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients [J].
Binggeli, S. ;
Egli, A. ;
Schaub, S. ;
Binet, I. ;
Mayr, M. ;
Steiger, J. ;
Hirsch, H. H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1131-1139
[7]   Cancer immunotherapy by interleukin-21: Potential treatment strategies evaluated in a mathematical model [J].
Cappuccio, Antonio ;
Elishmereni, Moran ;
Agur, Zvia .
CANCER RESEARCH, 2006, 66 (14) :7293-7300
[8]   Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation [J].
Chakera, A. ;
Bennett, S. ;
Lawrence, S. ;
Morteau, O. ;
Mason, P. D. ;
O'Callaghan, C. A. ;
Cornall, R. J. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 165 (03) :401-409
[9]   Polyomavirus-associated nephropathy: update on BK virus-specific immunity [J].
Comoli, P. ;
Binggeli, S. ;
Ginevri, F. ;
Hirsch, H. H. .
TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) :86-94
[10]   Cytomegalovirus and polyomavirus BK posttransplant [J].
Egli, Adrian ;
Binggeli, Simone ;
Bodaghi, Sohrab ;
Dumoulin, Alexis ;
Funk, Georg A. ;
Khanna, Nina ;
Leuenberger, David ;
Gosert, Rainer ;
Hirsch, Hans H. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 :72-82